https://www.live-feeds.com/feed/fda-elevates-thyroid-tablet-recall-to-most-serious-levelContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/fda-elevates-thyroid-tablet-recall-to-most-serious-levelhttps://www.live-feeds.com/feed/fda-elevates-thyroid-tablet-recall-to-most-serious-level#u84576Sat, 26 Sep 2026 02:32:20 +0000The FDA has upgraded a recall for thyroid medication to its most serious risk level. This classification, known as Class I, indicates the highest level of urgency for the drug recall. Multiple reports confirm the agency now views the situation as the most serious or urgent category available for such actions. Patients using the affected thyroid tablets should monitor official FDA guidance for specific batch information and safety instructions.Why it mattersClass I recalls are reserved for situations where there is a reasonable probability that use of a product will cause serious adverse health